Philip Nevin

Philip Nevin

Auto-generated profile, based on publicly available information

Philip Nevin

Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Structure
Verified
Journal Article
Closed access
JFJing Fang
Jing Fang
PNPhilip Nevin
Philip Nevin
VKVisvaldas Kairys
Visvaldas Kairys
ČVČeslovas Venclovas
Česlovas Venclovas
JEJohn R. Engen
John R. Engen
PBPenny Beuning
Penny Beuning

8 June 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
GSGiuseppina La Sala
Giuseppina La Sala
CPChristopher Pfleger
Christopher Pfleger
HKHelena Käck
Helena Käck
LWLisa Wissler
Lisa Wissler
PNPhilip Nevin
Philip Nevin
AFAndrey Frolov
Andrey Frolov
Structure-based three-parameter model that integrates local binding site information, coevolutionary information, and information on dynamic allostery to identify potentially hidden allosteric sites in ensembles of protein structures.


1 August 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PNPhilip Nevin
Philip Nevin
CGCarolina C. Gabbai
Carolina C. Gabbai
KMKenneth J. Marians
Kenneth J. Marians
Genome integrity relies on the ability of the replisome to navigate ubiquitous DNA damage during DNA replication. The Escherichia coli replisome transiently stalls at leading-strand template lesions and can either reinitiate replication downstream of the lesion or recruit specialized DNA polymerases that can bypass the lesion via translesion synthesis. Previous results had suggested that the E. coli replicase might play a role in lesion bypass, but this possibility has not been tested in reconstituted DNA replication systems. We report here that the DNA polymerase III holoenzyme in a stalled E. coli replisome can directly bypass a single cyclobutane pyrimidine dimer or abasic site by translesion synthesis in the absence of specialized translesion synthesis polymerases. Bypass efficiency was proportional to deoxynucleotide concentrations equivalent to those found in vivo and was dependent on the frequency of primer synthesis downstream of the lesion. Translesion synthesis came at the expense of lesion-skipping replication restart. Replication of a cyclobutane pyrimidine dimer was accurate, whereas replication of an abasic site resulted in mainly −1 frameshifts. Lesion bypass was accompanied by an increase in base substitution frequency for the base preceding the lesion. These findings suggest that DNA damage at the replication fork can be replicated directly by the replisome without the need to activate error-prone pathways.

22 April 2015 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
PNPhilip Nevin
Philip Nevin
XLXueguang Lu
Xueguang Lu
KZKe Zhang
Ke Zhang
JEJohn R. Engen
John R. Engen
PBPenny Beuning
Penny Beuning
Y‐family DNA polymerases are specialized to copy damaged DNA, and are associated with increased mutagenesis, owing to their low fidelity. It is believed that the mechanism of nucleotide selection by Y‐family DNA polymerases involves conformational changes preceding nucleotidyl transfer, but there is limited experimental evidence for such structural changes. In particular, nucleotide‐induced conformational changes in bacterial or eukaryotic Y‐family DNA polymerases have, to date, not been extensively characterized. Using hydrogen–deuterium exchange mass spectrometry, we demonstrate here that the Escherichia coli Y‐family DNA polymerase DinB and its human ortholog DNA polymerase κ undergo a conserved nucleotide‐induced conformational change in the presence of undamaged DNA and the correct incoming nucleotide. Notably, this holds true for damaged DNA containing N2‐furfuryl‐deoxyguanosine, which is efficiently copied by these two polymerases, but not for damaged DNA containing the major groove modification O6‐methyl‐deoxyguanosine, which is a poor substrate. Our observations suggest that DinB and DNA polymerase κ utilize a common mechanism for nucleotide selection involving a conserved prechemical conformational transition promoted by the correct nucleotide and only preferred DNA substrates.

9 February 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MSMichelle C. Silva
Michelle C. Silva
PNPhilip Nevin
Philip Nevin
ERErin A. Ronayne
Erin A. Ronayne
PBPenny Beuning
Penny Beuning
DNA polymerase III (DNA pol III) efficiently replicates the Escherichia coli genome, but it cannot bypass DNA damage. Instead, translesion synthesis (TLS) DNA polymerases are employed to replicate past damaged DNA; however, the exchange of replicative for TLS polymerases is not understood. The umuD gene products, which are up-regulated during the SOS response, were previously shown to bind to the α, β and ε subunits of DNA pol III. Full-length UmuD inhibits DNA replication and prevents mutagenic TLS, while the cleaved form UmuD′ facilitates mutagenesis. We show that α possesses two UmuD binding sites: at the N-terminus (residues 1–280) and the C-terminus (residues 956–975). The C-terminal site favors UmuD over UmuD′. We also find that UmuD, but not UmuD′, disrupts the α–β complex. We propose that the interaction between α and UmuD contributes to the transition between replicative and TLS polymerases by removing α from the β clamp.